Literature DB >> 35698856

Letter to the Editor: Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.

Pathum Sookaromdee1, Viroj Wiwanitkit2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35698856      PMCID: PMC9350105          DOI: 10.1002/ijgo.14289

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   4.447


× No keyword cloud information.
We would like to share ideas on the publication “Seroprevalence of SARS‐CoV‐2 antibodies among first‐trimester pregnant women during the second wave of the pandemic in India. ” According to Sharma et al., first‐trimester sero‐molecular screening indicates a significant incidence of COVID antibodies in the study group of pregnant women in the first trimester, even though the patients were asymptomatic. This report may contain helpful epidemiological information. The presence of asymptomatic COVID‐19 in any population group is undeniable. A high seropositive rate can be expected in a region with a high accumulated reported number of COVID‐19 cases. In terms of antibody testing, we should still be aware of the likelihood of a false positive in endemic areas. For example, dengue fever is common in tropical endemic countries, and dengue is a probable source of SARS‐CoV‐2 antibody‐test false positives. As a result, we must detect and evaluate the diagnostic features of antibody test kits for COVID‐19 serological research.
  2 in total

1.  Archived dengue serum samples produced false-positive results in SARS-CoV-2 lateral flow-based rapid antibody tests.

Authors:  Himadri Nath; Abinash Mallick; Subrata Roy; Soumi Sukla; Keya Basu; Abhishek De; Subhajit Biswas
Journal:  J Med Microbiol       Date:  2021-06       Impact factor: 2.472

2.  Seroprevalence of SARS-CoV-2 antibodies among first-trimester pregnant women during the second wave of the pandemic in India.

Authors:  Kandala Aparna Sharma; Nilanchali Singh; Sara Hillman; Purva Mathur; Kapil Yadav; Anapti Garg; Vatsla Dadhwal; Neerja Bhatla
Journal:  Int J Gynaecol Obstet       Date:  2022-03-24       Impact factor: 4.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.